Literature DB >> 1831679

Endothelial cells express the interleukin-1 receptor type I.

D Boraschi1, A Rambaldi, A Sica, P Ghiara, F Colotta, J M Wang, M de Rossi, C Zoia, G Remuzzi, F Bussolino.   

Abstract

Interleukin-1 (IL-1) profoundly affects a number of functions of vascular cells. Two distinct IL-1 receptors (IL-1R) are expressed on different cell types: the 80 Kd IL-1RI on T cells and fibroblasts, and the 68 Kd IL-1RII on B cells and myelomonocytic cells. The presence and functionality of IL-1R on vascular cells has been investigated by using polyomatransformed mouse endothelial cell (EC) lines (sEnd.1 and tEnd.1). These cells expressed specific and saturable binding sites for IL-1 (1,273 sites per cell with kd 9.5 x 10(-11) mol/L for sEnd.1, and 771 sites per cell with kd 8.5 x 10(-11) mol/L for tEnd.1, with radioiodinated IL-1 alpha as ligand). Binding of IL-1 was also evident at single cell level by autoradiography. By cross-linking studies, the molecular weight of the IL-1 binding protein on EC was approximately 80 Kd. This was confirmed by the presence in EC of mRNA for the 80 Kd IL-1RI. The IL-1RI on EC was apparently functional, since EC responded to IL-1 with IL-6 mRNA expression and IL-6 bioactivity production. These results were extended to human EC and vascular smooth muscle cells, which were also found to express mRNA for IL-1RI.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831679

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

2.  Expression analysis of the TAB2 protein in adult mouse tissues.

Authors:  C Orelio; E Dzierzak
Journal:  Inflamm Res       Date:  2007-03       Impact factor: 4.575

3.  Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells.

Authors:  J A Maier; M Statuto; G Ragnotti
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

4.  Interleukin-1β inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration.

Authors:  Sophie Lavalette; William Raoul; Marianne Houssier; Serge Camelo; Olivier Levy; Bertrand Calippe; Laurent Jonet; Francine Behar-Cohen; Sylvain Chemtob; Xavier Guillonneau; Christophe Combadière; Florian Sennlaub
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

5.  Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function.

Authors:  F Re; M Sironi; M Muzio; C Matteucci; M Introna; S Orlando; G Penton-Rol; S K Dower; J E Sims; F Colotta; A Mantovani
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

6.  Leukocyte-Released Mediators in Response to Both Bacterial and Fungal Infections Trigger IFN Pathways, Independent of IL-1 and TNF-α, in Endothelial Cells.

Authors:  Kieu T T Le; Xiaojing Chu; Martin Jaeger; Josée A Plantinga; Vasiliki Matzaraki; Sebo Withoff; Leo A B Joosten; Mihai G Netea; Cisca Wijmenga; Yang Li; Jill Moser; Vinod Kumar
Journal:  Front Immunol       Date:  2019-10-25       Impact factor: 7.561

7.  The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor.

Authors:  F Re; M Muzio; M De Rossi; N Polentarutti; J G Giri; A Mantovani; F Colotta
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

Review 8.  Active roles of dysfunctional vascular endothelium in fibrosis and cancer.

Authors:  Tien Hsu; Hieu-Huy Nguyen-Tran; Maria Trojanowska
Journal:  J Biomed Sci       Date:  2019-10-28       Impact factor: 8.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.